Name: Personalized Medicine in Oncology: Precision Oncology and Transformative Technologies (en Inglés)
SKU: 66690291
Price: 139.31 USD
Availability: InStock
Author: Hays, Priya

portada Personalized Medicine in Oncology: Precision Oncology and Transformative Technologies (en Inglés)

Personalized Medicine in Oncology: Precision Oncology and Transformative Technologies (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Hays, Priya

Idioma

Inglés

N° páginas

363

Encuadernación

Tapa Dura

ISBN13

9783032144362

Personalized Medicine in Oncology: Precision Oncology and Transformative Technologies (en Inglés)

Hays, Priya (Autor) · Springer · Tapa Dura

Libro Nuevo Importado

Envío: 20 a 27 días háb.

$ 253.30$ 139.31

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 139.31

Llega entre el 28 Sep y el 12 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Personalized Medicine in Oncology: Precision Oncology and Transformative Technologies (en Inglés)"

This book covers the field of precision oncology and is aligned with the targeted therapy drug development paradigm. Chapters present the relevance of immunotherapies as important and pivotal treatment strategies for cancer. The book outlines how Immune checkpoint inhibitors, CAR T cell therapies, antibody drug conjugates and bispecific antibodies evolved through the conduct of clinical trials and the resulting data to become critical components of the oncologist's armamentarium. The mechanism of each class is described in detail and how each has advantages and limitations concerning existing standards of care, demonstrating that they complement and contrast with each other; resistance mechanisms are also discussed. Targeted therapies for solid tumors and hematologic malignancies are explained in-depth. The roles of cancer genomics and liquid biopsy for precision oncology are also explored. This book sufficiently fills a gap by coalescing these studies into a thorough, yet clear compendium of these therapies. It describes the prognostic and predictive significance of each drug, biomarkers for determining their therapeutic potential, along with the assays (e.g., IHC) that evaluate them. Personalized Medicine in Oncology is a valuable resource for oncologists and clinicians as well as graduate medical students, cancer nurse practitioners, pharmacists, and clinicians in other related therapeutic areas of interest.